Follow the people · Insider
Quang X. Pham
Quang X. Pham files insider transactions with the SEC as a chairman and ceo of Cadrenal Therapeutics (CVKD). We hold 22 disclosed purchases and sales filed since 13 February 2023, 10 of them in the last 90 days.
- Files forCVKD
- Disclosed buys and sells22 in all, 10 in the last 90 days
- Last disclosure1 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 February 2023 — 29 June 2026Chairman and CEO · Cadrenal Therapeutics (CVKD)46 Form 4 lines · source: SEC Form 4
Everything they disclosed
46 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 7,400 shares of Cadrenal TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 2,127 shares of Cadrenal TherapeuticsSEC Form 426 June 2026Common Stock · traded 25 June 2026 · filed 26 June 2026
- ▼ sold on the open market 9,029 shares of Cadrenal TherapeuticsSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 9,167 shares of Cadrenal TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 2,277 shares of Cadrenal TherapeuticsSEC Form 424 June 2026Common Stock · traded 23 June 2026 · filed 24 June 2026
- ▼ sold on the open market 3,613 shares of Cadrenal TherapeuticsSEC Form 418 June 2026Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 513 shares of Cadrenal TherapeuticsSEC Form 418 June 2026Common Stock · traded 17 June 2026 · filed 18 June 2026
- ▼ sold on the open market 1,462 shares of Cadrenal TherapeuticsSEC Form 415 June 2026Common Stock · traded 11 June 2026 · filed 15 June 2026
- ▼ sold on the open market 12,996 shares of Cadrenal TherapeuticsSEC Form 415 June 2026Common Stock · traded 12 June 2026 · filed 15 June 2026
- ▼ sold on the open market 3,666 shares of Cadrenal TherapeuticsSEC Form 415 June 2026Common Stock · traded 15 June 2026 · filed 15 June 2026
- ▼ sold on the open market 5,893 shares of Cadrenal TherapeuticsSEC Form 410 June 2026Common Stock · traded 8 June 2026 · filed 10 June 2026
- ▼ sold on the open market 12,992 shares of Cadrenal TherapeuticsSEC Form 410 June 2026Common Stock · traded 9 June 2026 · filed 10 June 2026
- ▼ sold on the open market 3,500 shares of Cadrenal TherapeuticsSEC Form 410 June 2026Common Stock · traded 10 June 2026 · filed 10 June 2026
- ▼ sold on the open market 2,323 shares of Cadrenal TherapeuticsSEC Form 45 June 2026Common Stock · traded 3 June 2026 · filed 5 June 2026
- ▼ sold on the open market 3,898 shares of Cadrenal TherapeuticsSEC Form 45 June 2026Common Stock · traded 4 June 2026 · filed 5 June 2026
- ▼ sold on the open market 2,064 shares of Cadrenal TherapeuticsSEC Form 45 June 2026Common Stock · traded 5 June 2026 · filed 5 June 2026
- ▼ sold on the open market 303 shares of Cadrenal TherapeuticsSEC Form 42 June 2026Common Stock · traded 29 May 2026 · filed 2 June 2026
- ▼ sold on the open market 349 shares of Cadrenal TherapeuticsSEC Form 42 June 2026Common Stock · traded 2 June 2026 · filed 2 June 2026
- ▼ sold on the open market 6,476 shares of Cadrenal TherapeuticsSEC Form 429 May 2026Common Stock · traded 11 May 2026 · filed 29 May 2026
- ▼ sold on the open market 3,298 shares of Cadrenal TherapeuticsSEC Form 429 May 2026Common Stock · traded 12 May 2026 · filed 29 May 2026
- ▼ sold on the open market 2,989 shares of Cadrenal TherapeuticsSEC Form 429 May 2026Common Stock · traded 28 May 2026 · filed 29 May 2026
- ▼ sold on the open market 1,165 shares of Cadrenal TherapeuticsSEC Form 426 May 2026Common Stock · traded 22 May 2026 · filed 26 May 2026
- ▼ sold on the open market 1,129 shares of Cadrenal TherapeuticsSEC Form 428 October 2025Common Stock · traded 24 October 2025 · filed 28 October 2025
- ▼ sold on the open market 1,315 shares of Cadrenal TherapeuticsSEC Form 428 October 2025Common Stock · traded 27 October 2025 · filed 28 October 2025
- ▼ sold on the open market 1,800 shares of Cadrenal TherapeuticsSEC Form 414 October 2025Common Stock · traded 9 October 2025 · filed 14 October 2025
- ▼ sold on the open market 1,800 shares of Cadrenal TherapeuticsSEC Form 414 October 2025Common Stock · traded 13 October 2025 · filed 14 October 2025
- ▼ sold on the open market 500 shares of Cadrenal TherapeuticsSEC Form 43 October 2025Common Stock · traded 2 October 2025 · filed 3 October 2025
- ▼ sold on the open market 419 shares of Cadrenal TherapeuticsSEC Form 41 October 2025Common Stock · traded 29 September 2025 · filed 1 October 2025
- ▼ sold on the open market 881 shares of Cadrenal TherapeuticsSEC Form 41 October 2025Common Stock · traded 1 October 2025 · filed 1 October 2025
- ▼ sold on the open market 2,581 shares of Cadrenal TherapeuticsSEC Form 426 September 2025Common Stock · traded 24 September 2025 · filed 26 September 2025
- ▼ sold on the open market 6,790 shares of Cadrenal TherapeuticsSEC Form 426 September 2025Common Stock · traded 25 September 2025 · filed 26 September 2025
- ▼ sold on the open market 3,836 shares of Cadrenal TherapeuticsSEC Form 429 August 2025Common Stock · traded 27 August 2025 · filed 29 August 2025
- ▼ sold on the open market 1,193 shares of Cadrenal TherapeuticsSEC Form 429 August 2025Common Stock · traded 28 August 2025 · filed 29 August 2025
- was granted 65,000 shares of Cadrenal Therapeutics (a derivative holding)SEC Form 424 March 2025Stock Options · traded 23 January 2025 · filed 24 March 2025
- was granted 65,000 shares of Cadrenal Therapeutics (a derivative holding)SEC Form 424 January 2025Stock Options · traded 23 January 2025 · filed 24 January 2025
- gave away 50,000 shares of Cadrenal TherapeuticsSEC Form 410 April 2024Common Stock · traded 10 April 2024 · filed 10 April 2024
- gave away 85,000 shares of Cadrenal TherapeuticsSEC Form 412 February 2024Common Stock · traded 23 October 2023 · filed 12 February 2024
- was granted 150,000 shares of Cadrenal Therapeutics (a derivative holding)SEC Form 419 January 2024Stock Options · traded 18 January 2024 · filed 19 January 2024
- ▲ bought on the open market 20,000 shares of Cadrenal TherapeuticsSEC Form 46 September 2023Common Stock · traded 5 September 2023 · filed 6 September 2023
- ▲ bought on the open market 20,000 shares of Cadrenal TherapeuticsSEC Form 46 September 2023Common Stock · traded 5 September 2023 · filed 6 September 2023
- ▲ bought on the open market 10,000 shares of Cadrenal TherapeuticsSEC Form 45 September 2023Common Stock · traded 1 September 2023 · filed 5 September 2023
- ▲ bought on the open market 20,000 shares of Cadrenal TherapeuticsSEC Form 45 September 2023Common Stock · traded 1 September 2023 · filed 5 September 2023
- ▲ bought on the open market 20,000 shares of Cadrenal TherapeuticsSEC Form 45 September 2023Common Stock · traded 1 September 2023 · filed 5 September 2023
- ▲ bought on the open market 10,000 shares of Cadrenal TherapeuticsSEC Form 45 September 2023Common Stock · traded 1 September 2023 · filed 5 September 2023
- ▲ bought on the open market 10,000 shares of Cadrenal TherapeuticsSEC Form 45 September 2023Common Stock · traded 1 September 2023 · filed 5 September 2023
- was granted 25,000 shares of Cadrenal TherapeuticsSEC Form 413 February 2023Common Stock · traded 10 February 2023 · filed 13 February 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.